» Articles » PMID: 18046912

Principles of Soft Tissue Augmentation for the Aging Face

Overview
Publisher Dove Medical Press
Specialty Geriatrics
Date 2007 Dec 1
PMID 18046912
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

In the quest for the "ideal" soft tissue filler, many diverse products have been developed. The expanding market of available fillers is a testament that no one product will ideally suit all patients or clinicians. In addition, the challenge of satisfying the criteria of an ideal filler has driven researchers to take a variety of development paths. This has resulted in multiple categories to characterize soft tissue fillers. These fillers are categorized according to: (1) filler material, eg, autologous, natural, synthetic; (2) mechanism of action, eg, void filler, neocollagenesis, fibroblast stimulation; (3) patient type and profile, eg, younger versus older patient, rhytids versus "sinking and sagging" skin; or (4) durability of treatment effects, eg, temporary, semi-permanent, or permanent. Although strategies for soft tissue augmentation may be quite diverse, strategies should share a universal goal to address fat redistribution (atrophy and hypertrophy), the primary underlying morphological cause of facial aging. To accomplish this, volumizers are now available that are injected more deeply, resulting in the restoration of supportive structure and foundation. These can be used in combination with other products that are used more superficially for smoothing skin surfaces. As numerous soft tissue fillers enter the market, mechanisms and injection techniques become more divergent, and therefore require that the dermatologist and cosmetic surgeon receive adequate training to use products safely and effectively. This manuscript provides an overview of soft tissue fillers and their proper use.

Citing Articles

Poly-D,L-Lactic Acid Filler Attenuates Ultraviolet B-Induced Skin Pigmentation by Reducing Destruction of the Basement Membrane.

Byun K, Seo S, Oh S, Jang J, Son K, Byun K Int J Mol Sci. 2024; 25(21).

PMID: 39519119 PMC: 11546917. DOI: 10.3390/ijms252111568.


Autologous fat grafting for cosmetic temporal augmentation: a systematic review.

Nasim S, Nasim H, Kauke M, Safi A Front Surg. 2024; 11:1410162.

PMID: 39371685 PMC: 11449973. DOI: 10.3389/fsurg.2024.1410162.


Poly-D,L-Lactic Acid Filler Increases Extracellular Matrix by Modulating Macrophages and Adipose-Derived Stem Cells in Aged Animal Skin.

Oh S, Seo S, Kim G, Batsukh S, Park C, Son K Antioxidants (Basel). 2023; 12(6).

PMID: 37371934 PMC: 10294940. DOI: 10.3390/antiox12061204.


Thermistor-controlled subdermal skin tightening for the aging face: Clinical outcomes and efficacy.

Sanan A, Hjelm N, Tassone P, Krein H, Heffelfinger R Laryngoscope Investig Otolaryngol. 2019; 4(1):18-23.

PMID: 30828614 PMC: 6383317. DOI: 10.1002/lio2.228.


Osteoma Cutis and Tonsillolith: A Cone Beam Computed Tomography Study.

Abdelkarim A, Lozanoff S, Abu El Sadat S, Syed A Cureus. 2018; 10(7):e3003.

PMID: 30250765 PMC: 6145801. DOI: 10.7759/cureus.3003.


References
1.
James J, Carruthers A, Carruthers J . HIV-associated facial lipoatrophy. Dermatol Surg. 2002; 28(11):979-86. DOI: 10.1046/j.1524-4725.2002.02099.x. View

2.
Cheng J, Perkins S, Hamilton M . Collagen and injectable fillers. Otolaryngol Clin North Am. 2002; 35(1):73-85, vi. DOI: 10.1016/s0030-6665(03)00095-1. View

3.
Ascher B, Coleman S, Alster T, Bauer U, Burgess C, Butterwick K . Full scope of effect of facial lipoatrophy: a framework of disease understanding. Dermatol Surg. 2006; 32(8):1058-69. DOI: 10.1111/j.1524-4725.2006.32230.x. View

4.
Onesti M, Renzi L, Paoletti F, Scuderi N . Use of polylactic acid in face lipodystrophy in HIV positive patients undergoing treatment with antiretroviral drugs (HAART). Acta Chir Plast. 2004; 46(1):12-5. View

5.
Lupton J, Alster T . Cutaneous hypersensitivity reaction to injectable hyaluronic acid gel. Dermatol Surg. 2000; 26(2):135-7. DOI: 10.1046/j.1524-4725.2000.99202.x. View